Last reviewed · How we verify

NCT05983263: CAPSACOXp

Analgesic Efficacy of Capsaicin 8% Patch (QUTENZA®) in Coccygodygnia

Status unknown Last updated 9 August 2023
What this trial tests

trial testing Capsaicin in Coccyx Disorder in 106 participants. Status unknown.

Timeline
15 August 2023
Primary endpoint
17 December 2023
21 December 2023

Quick facts

Lead sponsorNantes University Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment106
Start date15 August 2023
Primary completion17 December 2023
Estimated completion21 December 2023

Drugs / interventions tested

Conditions studied

Sponsor

Nantes University Hospital

Who can join

Eligibility, any sex, with Coccyx Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A retrospective study over a period of 6 years to explore analgesic efficacy of 8% Capsaicin patch (QUTENZA®) in coccygodynic patients, as well as neuropathic predictive factors of therapeutic response.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Capsaicin

Trials testing the same drug.

Other recruiting trials for Coccyx Disorder

Currently open trials in the same condition.

Other Nantes University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05983263.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing